鶹Ƶ

skip to main content

ProfessionalsLina M. Dagnew

Lina M. Dagnew
Partner

Tel: +1-202-223-7455
Fax: +1-202-330-5027
ldagnew@paulweiss.com

+1-202-223-7455
Washington

2001 K Street, NW
Washington, DC 20006-1047
Fax: +1-202-330-5027

+ vCard ADD TO CONTACTS
Education 
Bar Admissions 
Education 
Bar Admissions 

A partner in the Litigation Department, Lina Dagnew is a trial lawyer who represents domestic and international clients in high-stakes disputes involving complex commercial litigation, sensitive internal investigations, white collar defense, employment, and Foreign Corrupt Practices Act matters. Lina regularly advises and represents financial institutions across a spectrum of matters, and has previously served as in-house counsel at one of the largest financial institutions. Lina also routinely represents companies and board members in M&A-related litigation in state and federal courts. Lina has jury trial experience at all levels and is well versed in all stages of critical litigation.

Experience

Lina was recently recognized by Lawdragon and named to “The 2024 Lawdragon 500 X – The Next Generation” and by Benchmark Litigation on its 2023 and 2024 “40 and Under Hot List” calling her an “emerging talent in white-collar crime litigation and investigations.” Lina’s representative matters include:

  • Citigroup in multiple complex commercial litigation matters in state and federal courts on variable rate debt obligations, including an antitrust class action and state-specific false claims act cases;
  • Citibank in the successful dismissal of a qui tam action brought under the Florida False Claims Act in connection with synthetic fixed-rate transactions with a notional value of $1 billion;
  • the special committee of the board of directors of QAD Inc., a leading provider of cloud-based enterprise software solutions, in a stockholder’s preliminary injunction motion in the Delaware Court of Chancery seeking to block a shareholder vote on QAD’s $2 billion merger with private equity firm Thoma Bravo and subsequent litigation;
  • the unaffiliated committee of a company’s board of directors in a M&A-related breach of fiduciary duty litigation;
  • the New York State Unified Court System in litigations in state and federal courts regarding the COVID-19 vaccine mandates for employees, nearly all of which have been successfully dismissed;
  • a pharmaceutical company in various lawsuits, including a putative class action, brought principally by health insurance companies in connection with copay foundations;
  • a financial institution in an employment-related lawsuit alleging claims under Title VII and state law;
  • General Atlantic, L.P. and individual defendants in a post-merger litigation in state and federal court;
  • the New York City Transit Authority in a breach of contract litigation in federal court;
  • a multinational chemical company in FCPA assessment of a potential target company;
  • the founder and former CEO of Premium Point Investments, a multibillion-dollar hedge fund, in a criminal securities fraud trial in the Southern District of New York involving allegations of mismarking; and
  • AbbVie in a bellwether trial in Illinois state court on testosterone replacement therapy products, obtaining a complete defense verdict.

Lina also maintains an active pro bono practice and has successfully represented clients in civil and criminal matters in state and federal courts as well as administrative proceedings. She serves on the board of the Urban Justice Center, an organization that incubates and accelerates early-stage social justice organizations. She is also a contributing author to the Anti-Bribery and Anti-Corruption Review, U.S. Chapter. During law school, Lina was a member of the Harvard Legal Aid Bureau, providing direct legal representation to vulnerable clients across legal issues.

© 2025 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy